ARS Pharmaceuticals, Inc. (SPRY)

USD 10.96

(-6.8%)

Revenue Summary of ARS Pharmaceuticals, Inc.

  • ARS Pharmaceuticals, Inc.'s latest annual revenue in 2023 was 30 Thousand USD , down -97.72% from previous year.
  • ARS Pharmaceuticals, Inc.'s latest quarterly revenue in 2024 Q2 was 500 Thousand USD , down 0.0% from previous quarter.
  • ARS Pharmaceuticals, Inc. reported a annual revenue of 1.31 Million USD in annual revenue 2022, down -76.1% from previous year.
  • ARS Pharmaceuticals, Inc. reported a annual revenue of 5.5 Million USD in annual revenue 2021, down -69.13% from previous year.
  • ARS Pharmaceuticals, Inc. reported a quarterly revenue of 500 Thousand USD for 2024 Q2, down 0.0% from previous quarter.
  • ARS Pharmaceuticals, Inc. reported a quarterly revenue of 10 Thousand USD for 2023 Q2, down -50.0% from previous quarter.

Annual Revenue Chart of ARS Pharmaceuticals, Inc. (2023 - 2018)

Historical Annual Revenue of ARS Pharmaceuticals, Inc. (2023 - 2018)

Year Revenue Revenue Growth
2023 30 Thousand USD -97.72%
2022 1.31 Million USD -76.1%
2021 5.5 Million USD -69.13%
2020 17.83 Million USD 0.0%
2019 - USD 0.0%
2018 - USD 0.0%

Peer Revenue Comparison of ARS Pharmaceuticals, Inc.

Name Revenue Revenue Difference
Acurx Pharmaceuticals, Inc. - USD -Infinity%
Adaptive Biotechnologies Corporation 170.27 Million USD 99.982%
IO Biotech, Inc. - USD -Infinity%
VYNE Therapeutics Inc. 424 Thousand USD 92.925%
Organovo Holdings, Inc. 109 Thousand USD 72.477%
TNF Pharmaceuticals, Inc. - USD -Infinity%
Lexaria Bioscience Corp. 226.2 Thousand USD 86.738%
Tonix Pharmaceuticals Holding Corp. 7.76 Million USD 99.614%
Aadi Bioscience, Inc. 24.35 Million USD 99.877%
Savara Inc. - USD -Infinity%
Aerovate Therapeutics, Inc. - USD -Infinity%
Rocket Pharmaceuticals, Inc. - USD -Infinity%
Corbus Pharmaceuticals Holdings, Inc. - USD -Infinity%
ZyVersa Therapeutics, Inc. - USD -Infinity%
Soligenix, Inc. 839.35 Thousand USD 96.426%
Aptose Biosciences Inc. - USD -Infinity%
NKGen Biotech, Inc. Common Stock - USD -Infinity%
Century Therapeutics, Inc. 2.23 Million USD 98.658%
Eterna Therapeutics Inc. 68 Thousand USD 55.882%
Precision BioSciences, Inc. 48.72 Million USD 99.938%
Axsome Therapeutics, Inc. 270.6 Million USD 99.989%
Kura Oncology, Inc. - USD -Infinity%
Xenetic Biosciences, Inc. 2.53 Million USD 98.819%
Dyadic International, Inc. 2.89 Million USD 98.965%
TScan Therapeutics, Inc. 21.04 Million USD 99.857%
IDEAYA Biosciences, Inc. 23.38 Million USD 99.872%
CytomX Therapeutics, Inc. 101.21 Million USD 99.97%
Autolus Therapeutics plc 1.69 Million USD 98.233%
Eton Pharmaceuticals, Inc. 31.64 Million USD 99.905%
EyePoint Pharmaceuticals, Inc. 46.01 Million USD 99.935%
GRI Bio, Inc. 21.76 Million USD 99.862%
Tenaya Therapeutics, Inc. - USD -Infinity%
IGM Biosciences, Inc. 2.13 Million USD 98.592%
Heron Therapeutics, Inc. 127.04 Million USD 99.976%
SAB Biotherapeutics, Inc. 2.23 Million USD 98.66%
Entero Therapeutics, Inc. - USD -Infinity%
Opthea Limited 261.85 Thousand USD 88.543%
X4 Pharmaceuticals, Inc. - USD -Infinity%
Atara Biotherapeutics, Inc. 8.57 Million USD 99.65%
Pliant Therapeutics, Inc. 1.58 Million USD 98.101%
Ligand Pharmaceuticals Incorporated 131.31 Million USD 99.977%
Surrozen, Inc. - USD -Infinity%
Lixte Biotechnology Holdings, Inc. - USD -Infinity%
Cingulate Inc. - USD -Infinity%
Ovid Therapeutics Inc. 391.69 Thousand USD 92.341%
Sorrento Therapeutics, Inc. 62.83 Million USD 99.952%
Acelyrin, Inc. - USD -Infinity%
Centessa Pharmaceuticals plc 6.85 Million USD 99.562%
Hepion Pharmaceuticals, Inc. - USD -Infinity%
Arcturus Therapeutics Holdings Inc. 157.74 Million USD 99.981%
Syros Pharmaceuticals, Inc. 9.93 Million USD 99.698%
ADMA Biologics, Inc. 258.21 Million USD 99.988%
PureTech Health plc 3.33 Million USD 99.099%
Oncternal Therapeutics, Inc. 785 Thousand USD 96.178%
FibroBiologics, Inc. Common Stock - USD -Infinity%
Barinthus Biotherapeutics plc 802 Thousand USD 96.259%
Kymera Therapeutics, Inc. 78.59 Million USD 99.962%
Synaptogenix, Inc. - USD -Infinity%
Tiziana Life Sciences Ltd - USD -Infinity%
ChromaDex Corporation 83.57 Million USD 99.964%
Inhibikase Therapeutics, Inc. 260.5 Thousand USD 88.484%
Monopar Therapeutics Inc. - USD -Infinity%
Exelixis, Inc. 1.83 Billion USD 99.998%
Akebia Therapeutics, Inc. 194.62 Million USD 99.985%
Better Therapeutics, Inc. - USD -Infinity%
Nurix Therapeutics, Inc. 76.98 Million USD 99.961%
Apellis Pharmaceuticals, Inc. 396.59 Million USD 99.992%
Sangamo Therapeutics, Inc. 176.23 Million USD 99.983%
Seer, Inc. 15.18 Million USD 99.802%
Aridis Pharmaceuticals, Inc. - USD -Infinity%
LAVA Therapeutics N.V. 6.76 Million USD 99.557%
Gritstone bio, Inc. 1.33 Million USD 97.746%
Jasper Therapeutics, Inc. - USD -Infinity%
Avid Bioservices, Inc. 139.91 Million USD 99.979%
Insmed Incorporated 305.2 Million USD 99.99%
Panbela Therapeutics, Inc. - USD -Infinity%
Avalo Therapeutics, Inc. 1.92 Million USD 98.441%
Fate Therapeutics, Inc. 63.53 Million USD 99.953%
MediWound Ltd. 18.68 Million USD 99.839%
BioXcel Therapeutics, Inc. 1.38 Million USD 97.826%
Fortress Biotech, Inc. 84.51 Million USD 99.965%
OmniAb, Inc. 34.16 Million USD 99.912%
Seres Therapeutics, Inc. 126.32 Million USD 99.976%
Zai Lab Limited 266.71 Million USD 99.989%
Revance Therapeutics, Inc. 234.04 Million USD 99.987%
Tarsus Pharmaceuticals, Inc. 17.44 Million USD 99.828%
Veracyte, Inc. 361.05 Million USD 99.992%
Abeona Therapeutics Inc. 3.5 Million USD 99.143%
FibroGen, Inc. 147.75 Million USD 99.98%
Apogee Therapeutics, Inc. - USD -Infinity%
ContextLogic Inc. 287 Million USD 99.99%
Intensity Therapeutics, Inc. - USD -Infinity%
Adial Pharmaceuticals, Inc. - USD -Infinity%
HOOKIPA Pharma Inc. 20.12 Million USD 99.851%
Jazz Pharmaceuticals plc 3.83 Billion USD 99.999%
Entrada Therapeutics, Inc. 129.01 Million USD 99.977%
Cyclacel Pharmaceuticals, Inc. 420 Thousand USD 92.857%
ImmuCell Corporation 17.47 Million USD 99.828%
Fortrea Holdings Inc. 3.1 Billion USD 99.999%
KalVista Pharmaceuticals, Inc. - USD -Infinity%
Jasper Therapeutics, Inc. - USD -Infinity%
Foghorn Therapeutics Inc. 34.15 Million USD 99.912%
Ultragenyx Pharmaceutical Inc. 434.24 Million USD 99.993%
Theravance Biopharma, Inc. 57.42 Million USD 99.948%
Metagenomi, Inc. Common Stock 44.75 Million USD 99.933%
Vaxxinity, Inc. - USD -Infinity%
BioCryst Pharmaceuticals, Inc. 331.41 Million USD 99.991%
Gain Therapeutics, Inc. 55.18 Thousand USD 45.632%
Creative Medical Technology Holdings, Inc. 9000.00 USD -233.333%
Marker Therapeutics, Inc. 3.31 Million USD 99.094%
CASI Pharmaceuticals, Inc. 33.87 Million USD 99.911%
Senti Biosciences, Inc. 2.56 Million USD 98.829%
BioRestorative Therapies, Inc. 145.8 Thousand USD 79.424%
Apollomics, Inc. 821 Thousand USD 96.346%
89bio, Inc. - USD -Infinity%
Arrowhead Pharmaceuticals, Inc. 240.73 Million USD 99.988%
TransCode Therapeutics, Inc. - USD -Infinity%
RAPT Therapeutics, Inc. - USD -Infinity%
Ardelyx, Inc. 124.45 Million USD 99.976%
Pluri Inc. 326 Thousand USD 90.798%
Prothena Corporation plc 91.37 Million USD 99.967%
Pulmatrix, Inc. 7.29 Million USD 99.589%
Celularity Inc. 22.77 Million USD 99.868%
MeiraGTx Holdings plc 14.01 Million USD 99.786%
Omeros Corporation - USD -Infinity%
Ainos, Inc. 122.11 Thousand USD 75.432%
Humacyte, Inc. - USD -Infinity%
Mesoblast Limited 5.9 Million USD 99.492%
Cocrystal Pharma, Inc. - USD -Infinity%
Cidara Therapeutics, Inc. 63.9 Million USD 99.953%
Blueprint Medicines Corporation 249.38 Million USD 99.988%
Cabaletta Bio, Inc. - USD -Infinity%
Summit Therapeutics Inc. - USD -Infinity%
Alaunos Therapeutics, Inc. 5000.00 USD -500.0%
Scholar Rock Holding Corporation - USD -Infinity%
Intellia Therapeutics, Inc. 36.27 Million USD 99.917%
Adlai Nortye Ltd. American Depositary Shares 4.99 Million USD 99.399%
Cytokinetics, Incorporated 7.53 Million USD 99.602%
Eloxx Pharmaceuticals, Inc. - USD -Infinity%
Nutriband Inc. 2.08 Million USD 98.561%
Protara Therapeutics, Inc. - USD -Infinity%
Roivant Sciences Ltd. 124.79 Million USD 99.976%
Evogene Ltd. 5.64 Million USD 99.468%
Applied Therapeutics, Inc. 9.99 Million USD 99.7%
Hoth Therapeutics, Inc. - USD -Infinity%
BridgeBio Pharma, Inc. 9.3 Million USD 99.678%
BioLineRx Ltd. 4.8 Million USD 99.375%
Atai Life Sciences N.V. 314 Thousand USD 90.446%
VistaGen Therapeutics, Inc. 1.06 Million USD 97.18%
Aurinia Pharmaceuticals Inc. 175.51 Million USD 99.983%
MediciNova, Inc. 1 Million USD 97.0%
Praxis Precision Medicines, Inc. 2.44 Million USD 98.774%
MiMedx Group, Inc. 321.47 Million USD 99.991%
PTC Therapeutics, Inc. 937.82 Million USD 99.997%
Cullinan Oncology, Inc. - USD -Infinity%
Syndax Pharmaceuticals, Inc. - USD -Infinity%
Pasithea Therapeutics Corp. - USD -Infinity%
NRx Pharmaceuticals, Inc. - USD -Infinity%
4D Molecular Therapeutics, Inc. 20.72 Million USD 99.855%
Dyne Therapeutics, Inc. - USD -Infinity%
Kiniksa Pharmaceuticals, Ltd. 270.25 Million USD 99.989%
Ventyx Biosciences, Inc. - USD -Infinity%
Allakos Inc. - USD -Infinity%
Fulcrum Therapeutics, Inc. 2.8 Million USD 98.93%
Corcept Therapeutics Incorporated 482.37 Million USD 99.994%
BioAtla, Inc. - USD -Infinity%
Allogene Therapeutics, Inc. 95 Thousand USD 68.421%
Larimar Therapeutics, Inc. - USD -Infinity%
Precigen, Inc. 6.22 Million USD 99.518%
BriaCell Therapeutics Corp. - USD -Infinity%
XOMA Corporation 4.75 Million USD 99.369%
Kezar Life Sciences, Inc. 7 Million USD 99.571%
Incyte Corporation 3.69 Billion USD 99.999%
Cara Therapeutics, Inc. 20.96 Million USD 99.857%
Aligos Therapeutics, Inc. 15.52 Million USD 99.807%
Reviva Pharmaceuticals Holdings, Inc. - USD -Infinity%
CRISPR Therapeutics AG 371.2 Million USD 99.992%
Akero Therapeutics, Inc. - USD -Infinity%
Eliem Therapeutics, Inc. - USD -Infinity%
EyeGate Pharmaceuticals, Inc. 12.05 Thousand USD -148.777%
UroGen Pharma Ltd. 82.71 Million USD 99.964%
Sutro Biopharma, Inc. 153.73 Million USD 99.98%
ZIVO Bioscience, Inc. 27.65 Thousand USD -8.499%
Lisata Therapeutics, Inc. - USD -Infinity%
Stoke Therapeutics, Inc. 8.78 Million USD 99.658%
Chimerix, Inc. 324 Thousand USD 90.741%
Outlook Therapeutics, Inc. - USD -Infinity%
60 Degrees Pharmaceuticals, Inc. 253.57 Thousand USD 88.169%
Enanta Pharmaceuticals, Inc. 79.2 Million USD 99.962%
Aprea Therapeutics, Inc. 583.23 Thousand USD 94.856%
Portage Biotech Inc. - USD -Infinity%
OncoCyte Corporation 1.5 Million USD 98.004%
Qualigen Therapeutics, Inc. 5.2 Million USD 99.424%
Cadrenal Therapeutics, Inc. Common Stock - USD -Infinity%
Processa Pharmaceuticals, Inc. - USD -Infinity%
Purple Biotech Ltd. - USD -Infinity%
NextCure, Inc. - USD -Infinity%
ProMIS Neurosciences, Inc. - USD -Infinity%
Dermata Therapeutics, Inc. - USD -Infinity%
Generation Bio Co. 5.9 Million USD 99.492%
Neumora Therapeutics, Inc. Common Stock - USD -Infinity%
Xeris Biopharma Holdings, Inc. 163.91 Million USD 99.982%
TRACON Pharmaceuticals, Inc. 12.04 Million USD 99.751%
NLS Pharmaceutics AG - USD -Infinity%
Mineralys Therapeutics, Inc. - USD -Infinity%
Novavax, Inc. 983.7 Million USD 99.997%
Virios Therapeutics, Inc. - USD -Infinity%
Curis, Inc. 10.02 Million USD 99.701%
Daré Bioscience, Inc. 2.8 Million USD 98.932%
Titan Pharmaceuticals, Inc. 184 Thousand USD 83.696%
Virpax Pharmaceuticals, Inc. - USD -Infinity%
Bicycle Therapeutics plc 26.97 Million USD 99.889%
BeiGene, Ltd. 2.45 Billion USD 99.999%
Kiromic BioPharma, Inc. - USD -Infinity%
Alector, Inc. 97.06 Million USD 99.969%
Protagonist Therapeutics, Inc. 60 Million USD 99.95%
Erasca, Inc. - USD -Infinity%
Checkpoint Therapeutics, Inc. 103 Thousand USD 70.874%
Aura Biosciences, Inc. - USD -Infinity%
Viracta Therapeutics, Inc. - USD -Infinity%
Chemomab Therapeutics Ltd. - USD -Infinity%
Protagenic Therapeutics, Inc. - USD -Infinity%
Pieris Pharmaceuticals, Inc. 42.81 Million USD 99.93%
BioMarin Pharmaceutical Inc. 2.41 Billion USD 99.999%
Histogen Inc. 3.76 Million USD 99.204%
Fortress Biotech, Inc. 84.51 Million USD 99.965%
Avidity Biosciences, Inc. 9.56 Million USD 99.686%
Lyell Immunopharma, Inc. 130 Thousand USD 76.923%
Galecto, Inc. - USD -Infinity%
InMed Pharmaceuticals Inc. 4.59 Million USD 99.348%
Phathom Pharmaceuticals, Inc. 682 Thousand USD 95.601%
Molecular Templates, Inc. 57.3 Million USD 99.948%
PDS Biotechnology Corporation - USD -Infinity%
Amylyx Pharmaceuticals, Inc. 380.78 Million USD 99.992%
Amarin Corporation plc 306.91 Million USD 99.99%
TG Therapeutics, Inc. 233.66 Million USD 99.987%
Aptevo Therapeutics Inc. - USD -Infinity%
Celldex Therapeutics, Inc. 6.88 Million USD 99.564%
Cogent Biosciences, Inc. - USD -Infinity%
Onconetix, Inc. 58.46 Thousand USD 48.687%
MacroGenics, Inc. 58.74 Million USD 99.949%
Y-mAbs Therapeutics, Inc. 84.81 Million USD 99.965%
Ocuphire Pharma, Inc. 19.04 Million USD 99.843%
Adagene Inc. 18.11 Million USD 99.834%
Inhibrx Biosciences, Inc. 1.8 Million USD 98.333%
Cartesian Therapeutics, Inc. 26 Million USD 99.885%
Voyager Therapeutics, Inc. 250 Million USD 99.988%
SciSparc Ltd. 2.87 Million USD 98.958%
Revelation Biosciences, Inc. - USD -Infinity%
Minerva Neurosciences, Inc. - USD -Infinity%
Astria Therapeutics, Inc. - USD -Infinity%
Black Diamond Therapeutics, Inc. - USD -Infinity%
Arcutis Biotherapeutics, Inc. 59.6 Million USD 99.95%
Relay Therapeutics, Inc. 25.54 Million USD 99.883%
Alnylam Pharmaceuticals, Inc. 1.82 Billion USD 99.998%
Psyence Biomedical Ltd. - USD -Infinity%
Artelo Biosciences, Inc. - USD -Infinity%
2seventy bio, Inc. 100.38 Million USD 99.97%
Clene Inc. 654 Thousand USD 95.413%
Boundless Bio, Inc. Common Stock - USD -Infinity%
GeoVax Labs, Inc. - USD -Infinity%
Sonnet BioTherapeutics Holdings, Inc. 147.8 Thousand USD 79.703%
Arbutus Biopharma Corporation 18.14 Million USD 99.835%
Scopus BioPharma Inc. - USD -Infinity%
Absci Corporation 5.71 Million USD 99.475%
XBiotech Inc. - USD -Infinity%
ALX Oncology Holdings Inc. - USD -Infinity%
Lyra Therapeutics, Inc. 1.55 Million USD 98.074%
Entera Bio Ltd. - USD -Infinity%
Trevena, Inc. 3.12 Million USD 99.04%
Adaptimmune Therapeutics plc 60.28 Million USD 99.95%
Caribou Biosciences, Inc. 34.47 Million USD 99.913%
INmune Bio, Inc. 155 Thousand USD 80.645%
Citius Pharmaceuticals, Inc. - USD -Infinity%
Tyra Biosciences, Inc. - USD -Infinity%
Galmed Pharmaceuticals Ltd. - USD -Infinity%
Unity Biotechnology, Inc. - USD -Infinity%
Tenax Therapeutics, Inc. - USD -Infinity%
Jaguar Health, Inc. 9.76 Million USD 99.693%
Clearside Biomedical, Inc. 8.22 Million USD 99.635%
NexImmune, Inc. - USD -Infinity%
Connect Biopharma Holdings Limited - USD -Infinity%
Clearmind Medicine Inc. - USD -Infinity%
Coeptis Therapeutics Holdings, Inc. - USD -Infinity%
Kronos Bio, Inc. 6.28 Million USD 99.523%
Innoviva, Inc. 310.46 Million USD 99.99%
Coherus BioSciences, Inc. 257.24 Million USD 99.988%
Regeneron Pharmaceuticals, Inc. 13.11 Billion USD 100.0%
Bolt Biotherapeutics, Inc. 7.87 Million USD 99.619%
Verastem, Inc. - USD -Infinity%
ProKidney Corp. - USD -Infinity%
CERo Therapeutics Holdings, Inc. - USD -Infinity%
Imunon, Inc. - USD -Infinity%
Viking Therapeutics, Inc. - USD -Infinity%
Statera Biopharma, Inc. - USD -Infinity%
ImmunityBio, Inc. 622 Thousand USD 95.177%
Korro Bio, Inc. - USD -Infinity%
Travere Therapeutics, Inc. 145.23 Million USD 99.979%
Kineta, Inc. 5.44 Million USD 99.449%
Catalyst Pharmaceuticals, Inc. 398.2 Million USD 99.992%
Capricor Therapeutics, Inc. 25.17 Million USD 99.881%
GT Biopharma, Inc. - USD -Infinity%
Keros Therapeutics, Inc. 151 Thousand USD 80.132%
Celularity Inc. 22.77 Million USD 99.868%
Crinetics Pharmaceuticals, Inc. 4.01 Million USD 99.252%
CalciMedica, Inc. - USD -Infinity%
Cibus, Inc. 1.81 Million USD 98.349%
C4 Therapeutics, Inc. 20.75 Million USD 99.855%
Marinus Pharmaceuticals, Inc. 30.98 Million USD 99.903%
Eledon Pharmaceuticals, Inc. - USD -Infinity%
Kodiak Sciences Inc. - USD -Infinity%
Sana Biotechnology, Inc. - USD -Infinity%
Annexon, Inc. - USD -Infinity%
Adverum Biotechnologies, Inc. 3.6 Million USD 99.167%
Assembly Biosciences, Inc. 7.16 Million USD 99.581%
Elicio Therapeutics, Inc. - USD -Infinity%
Moderna, Inc. 6.84 Billion USD 100.0%
Vigil Neuroscience, Inc. - USD -Infinity%
Ionis Pharmaceuticals, Inc. 787.64 Million USD 99.996%
Vor Biopharma Inc. - USD -Infinity%
Eyenovia, Inc. 3787.00 USD -692.184%
DiaMedica Therapeutics Inc. - USD -Infinity%
Puma Biotechnology, Inc. 235.63 Million USD 99.987%
Monte Rosa Therapeutics, Inc. - USD -Infinity%
Wave Life Sciences Ltd. 113.3 Million USD 99.974%
Conduit Pharmaceuticals Inc. - USD -Infinity%
ACADIA Pharmaceuticals Inc. 726.43 Million USD 99.996%
Immunocore Holdings plc 249.42 Million USD 99.988%
Tango Therapeutics, Inc. 36.52 Million USD 99.918%
Galectin Therapeutics Inc. - USD -Infinity%
Alkermes plc 1.66 Billion USD 99.998%
Arcellx, Inc. 110.31 Million USD 99.973%
Renovaro Biosciences Inc. - USD -Infinity%
Zentalis Pharmaceuticals, Inc. - USD -Infinity%
Sagimet Biosciences Inc. 2 Million USD 98.5%
Regulus Therapeutics Inc. - USD -Infinity%
Cardio Diagnostics Holdings, Inc. 17.06 Thousand USD -75.798%
Moolec Science SA 905.04 Thousand USD 96.685%
Biomea Fusion, Inc. - USD -Infinity%
RenovoRx, Inc. - USD -Infinity%
Geron Corporation 237 Thousand USD 87.342%
Mereo BioPharma Group plc 10 Million USD 99.7%
Verrica Pharmaceuticals Inc. 5.12 Million USD 99.415%
Royalty Pharma plc 2.35 Billion USD 99.999%
Atea Pharmaceuticals, Inc. - USD -Infinity%
Greenwich LifeSciences, Inc. - USD -Infinity%
Calithera Biosciences, Inc. - USD -Infinity%
TFF Pharmaceuticals, Inc. 733.87 Thousand USD 95.912%
Mersana Therapeutics, Inc. 36.85 Million USD 99.919%
Humacyte, Inc. - USD -Infinity%
Structure Therapeutics Inc. - USD -Infinity%
NLS Pharmaceutics AG - USD -Infinity%
Genelux Corporation 170 Thousand USD 82.353%
ESSA Pharma Inc. - USD -Infinity%
aTyr Pharma, Inc. 353 Thousand USD 91.501%
Notable Labs, Ltd. 310 Thousand USD 90.323%
Alzamend Neuro, Inc. - USD -Infinity%
Mustang Bio, Inc. - USD -Infinity%
Immunovant, Inc. - USD -Infinity%
Tevogen Bio Holdings Inc. - USD -Infinity%
Vericel Corporation 197.51 Million USD 99.985%
Halozyme Therapeutics, Inc. 829.25 Million USD 99.996%
Akari Therapeutics, Plc - USD -Infinity%
Acasti Pharma Inc. - USD -Infinity%
MiNK Therapeutics, Inc. - USD -Infinity%
Vaxcyte, Inc. - USD -Infinity%
Orgenesis Inc. 530 Thousand USD 94.34%
Spruce Biosciences, Inc. 10.08 Million USD 99.703%
NeuroBo Pharmaceuticals, Inc. - USD -Infinity%
GH Research PLC - USD -Infinity%
Tempest Therapeutics, Inc. - USD -Infinity%
PepGen Inc. - USD -Infinity%
Moleculin Biotech, Inc. - USD -Infinity%
Relmada Therapeutics, Inc. - USD -Infinity%
BriaCell Therapeutics Corp. - USD -Infinity%
Lixte Biotechnology Holdings, Inc. - USD -Infinity%
Silo Pharma, Inc. 72.1 Thousand USD 58.392%
Telomir Pharmaceuticals, Inc. Common Stock - USD -Infinity%
Belite Bio, Inc - USD -Infinity%
Pharming Group N.V. 245.31 Million USD 99.988%
XOMA Corporation 4.75 Million USD 99.369%
Reneo Pharmaceuticals, Inc. - USD -Infinity%
Reviva Pharmaceuticals Holdings, Inc. - USD -Infinity%
Bionomics Limited - USD -Infinity%
Xencor, Inc. 168.33 Million USD 99.982%
Replimune Group, Inc. - USD -Infinity%
Pyxis Oncology, Inc. - USD -Infinity%
Cassava Sciences, Inc. - USD -Infinity%
Vanda Pharmaceuticals Inc. 192.64 Million USD 99.984%
Estrella Immunopharma, Inc. - USD -Infinity%
Turnstone Biologics Corp. 19.3 Million USD 99.845%
Windtree Therapeutics, Inc. - USD -Infinity%
GeoVax Labs, Inc. - USD -Infinity%
MEI Pharma, Inc. 65.29 Million USD 99.954%
Olema Pharmaceuticals, Inc. - USD -Infinity%
Cardio Diagnostics Holdings, Inc. 17.06 Thousand USD -75.798%
Bio-Path Holdings, Inc. - USD -Infinity%
Enlivex Therapeutics Ltd. - USD -Infinity%
CollPlant Biotechnologies Ltd. 10.95 Million USD 99.726%
scPharmaceuticals Inc. 13.59 Million USD 99.779%
HilleVax, Inc. - USD -Infinity%
Vera Therapeutics, Inc. 1.86 Million USD 98.389%
Tharimmune, Inc. - USD -Infinity%
Genprex, Inc. - USD -Infinity%
SeaStar Medical Holding Corporation - USD -Infinity%
Immunic, Inc. - USD -Infinity%
Atossa Therapeutics, Inc. - USD -Infinity%
Aptorum Group Limited 431.37 Thousand USD 93.046%
Soleno Therapeutics, Inc. - USD -Infinity%
SeaStar Medical Holding Corporation - USD -Infinity%
OKYO Pharma Limited - USD -Infinity%
Carmell Therapeutics Corporation - USD -Infinity%
Achieve Life Sciences, Inc. - USD -Infinity%
Ocean Biomedical, Inc. - USD -Infinity%
Amicus Therapeutics, Inc. 399.35 Million USD 99.992%
Salarius Pharmaceuticals, Inc. - USD -Infinity%
bluebird bio, Inc. 29.49 Million USD 99.898%
DBV Technologies S.A. 15.72 Million USD 99.809%
Compugen Ltd. 33.45 Million USD 99.91%
Protagenic Therapeutics, Inc. - USD -Infinity%
Peak Bio, Inc. 367.87 Thousand USD 91.845%
Vincerx Pharma, Inc. - USD -Infinity%
Fresh Tracks Therapeutics, Inc. 8 Million USD 99.625%
Sensei Biotherapeutics, Inc. - USD -Infinity%
Orchestra BioMed Holdings, Inc. 2.76 Million USD 98.913%
Zevra Therapeutics, Inc. 27.46 Million USD 99.891%
Acrivon Therapeutics, Inc. Common Stock - USD -Infinity%
Benitec Biopharma Inc. 216 Thousand USD 86.111%
Spyre Therapeutics, Inc. 886 Thousand USD 96.614%
Adicet Bio, Inc. - USD -Infinity%
Prime Medicine, Inc. - USD -Infinity%
Aditxt, Inc. 645.17 Thousand USD 95.35%
Madrigal Pharmaceuticals, Inc. - USD -Infinity%
Estrella Immunopharma, Inc. - USD -Infinity%
Quantum-Si incorporated 1.08 Million USD 97.227%
GlycoMimetics, Inc. 10 Thousand USD -200.0%
PolyPid Ltd. - USD -Infinity%
Aileron Therapeutics, Inc. - USD -Infinity%
Invivyd, Inc. - USD -Infinity%
Quoin Pharmaceuticals, Ltd. - USD -Infinity%
Rigel Pharmaceuticals, Inc. 116.88 Million USD 99.974%
CorMedix Inc. - USD -Infinity%
Instil Bio, Inc. - USD -Infinity%
Recursion Pharmaceuticals, Inc. 44.57 Million USD 99.933%
Contineum Therapeutics, Inc. Class A Common Stock 50 Million USD 99.94%
Finch Therapeutics Group, Inc. 107 Thousand USD 71.963%
Spero Therapeutics, Inc. 96.73 Million USD 99.969%
Alpha Tau Medical Ltd. - USD -Infinity%
AbCellera Biologics Inc. 38.02 Million USD 99.921%
Ocular Therapeutix, Inc. 58.44 Million USD 99.949%
Surrozen, Inc. - USD -Infinity%
Janux Therapeutics, Inc. 8.08 Million USD 99.629%
Verona Pharma plc - USD -Infinity%
Terns Pharmaceuticals, Inc. - USD -Infinity%
Vir Biotechnology, Inc. 86.18 Million USD 99.965%
Evaxion Biotech A/S 73.11 Thousand USD 58.967%
Verve Therapeutics, Inc. 11.75 Million USD 99.745%
Shattuck Labs, Inc. 1.65 Million USD 98.189%
AlloVir, Inc. - USD -Infinity%
BioVie Inc. - USD -Infinity%
Codexis, Inc. 70.14 Million USD 99.957%
SELLAS Life Sciences Group, Inc. - USD -Infinity%
Lexaria Bioscience Corp. 226.2 Thousand USD 86.738%
Agenus Inc. 156.31 Million USD 99.981%
Virax Biolabs Group Limited 156.41 Thousand USD 80.821%
Lantern Pharma Inc. - USD -Infinity%
Viridian Therapeutics, Inc. 314 Thousand USD 90.446%
eFFECTOR Therapeutics, Inc. - USD -Infinity%
Immix Biopharma, Inc. - USD -Infinity%
Celcuity Inc. - USD -Infinity%
Cardiff Oncology, Inc. 488 Thousand USD 93.852%
Acumen Pharmaceuticals, Inc. - USD -Infinity%
IN8bio, Inc. - USD -Infinity%
Avenue Therapeutics, Inc. - USD -Infinity%
Trevi Therapeutics, Inc. - USD -Infinity%
Lexicon Pharmaceuticals, Inc. 1.2 Million USD 97.508%
Liquidia Corporation 17.48 Million USD 99.828%
Quantum-Si incorporated 1.08 Million USD 97.227%
Pasithea Therapeutics Corp. - USD -Infinity%
Xenon Pharmaceuticals Inc. - USD -Infinity%
Sol-Gel Technologies Ltd. 1.55 Million USD 98.069%
United Therapeutics Corporation 2.32 Billion USD 99.999%
Solid Biosciences Inc. - USD -Infinity%
Immuneering Corporation - USD -Infinity%
Alpha Tau Medical Ltd. - USD -Infinity%
uniQure N.V. 15.84 Million USD 99.811%
Xilio Therapeutics, Inc. - USD -Infinity%
Enveric Biosciences, Inc. - USD -Infinity%
Poseida Therapeutics, Inc. 64.7 Million USD 99.954%
Longboard Pharmaceuticals, Inc. - USD -Infinity%
PMV Pharmaceuticals, Inc. - USD -Infinity%
Elevai Labs, Inc. Common Stock 1.71 Million USD 98.248%
Cue Biopharma, Inc. 5.49 Million USD 99.454%
Nuvectis Pharma, Inc. - USD -Infinity%
Zura Bio Limited - USD -Infinity%
Forte Biosciences, Inc. - USD -Infinity%
Elevation Oncology, Inc. - USD -Infinity%
Conduit Pharmaceuticals Inc. - USD -Infinity%
Immunome, Inc. 14.01 Million USD 99.786%
Compass Therapeutics, Inc. - USD -Infinity%
enGene Holdings Inc. Warrants - USD -Infinity%
Inovio Pharmaceuticals, Inc. 832.01 Thousand USD 96.394%
LENZ Therapeutics, Inc. - USD -Infinity%
Altimmune, Inc. 426 Thousand USD 92.958%
Milestone Pharmaceuticals Inc. 1 Million USD 97.0%
Rallybio Corporation - USD -Infinity%
Plus Therapeutics, Inc. 4.91 Million USD 99.389%
Dianthus Therapeutics, Inc. 2.82 Million USD 98.938%
Moolec Science SA 905.04 Thousand USD 96.685%
Anebulo Pharmaceuticals, Inc. - USD -Infinity%
XTL Biopharmaceuticals Ltd. - USD -Infinity%
Tourmaline Bio, Inc. - USD -Infinity%
NeurAxis, Inc. 2.46 Million USD 98.781%
Maravai LifeSciences Holdings, Inc. 288.94 Million USD 99.99%
Lumos Pharma, Inc. 2.05 Million USD 98.537%
enGene Holdings Inc. Common Stock - USD -Infinity%
180 Life Sciences Corp. - USD -Infinity%
NKGen Biotech, Inc. Warrants - USD -Infinity%
Opiant Pharmaceuticals, Inc. 40.72 Million USD 99.926%
CERo Therapeutics Holdings, Inc. - USD -Infinity%
Nutriband Inc. 2.08 Million USD 98.561%
CG Oncology, Inc. Common stock 204 Thousand USD 85.294%
argenx SE 1.22 Billion USD 99.998%
Neurogene Inc. - USD -Infinity%
Mirum Pharmaceuticals, Inc. 186.37 Million USD 99.984%
Kintara Therapeutics, Inc. - USD -Infinity%
CervoMed Inc. 7.14 Million USD 99.58%
CARGO Therapeutics, Inc. Common Stock - USD -Infinity%
Sesen Bio, Inc. 40 Million USD 99.925%
AnaptysBio, Inc. 17.15 Million USD 99.825%
Design Therapeutics, Inc. - USD -Infinity%
Leap Therapeutics, Inc. - USD -Infinity%
Seelos Therapeutics, Inc. 2.2 Million USD 98.638%
Achilles Therapeutics plc - USD -Infinity%
NeuroSense Therapeutics Ltd. - USD -Infinity%
ORIC Pharmaceuticals, Inc. - USD -Infinity%
Fractyl Health, Inc. Common Stock 120 Thousand USD 75.0%
Rani Therapeutics Holdings, Inc. - USD -Infinity%
MoonLake Immunotherapeutics - USD -Infinity%
Palisade Bio, Inc. 250 Thousand USD 88.0%
Beam Therapeutics Inc. 377.7 Million USD 99.992%
AEON Biopharma, Inc. - USD -Infinity%
Enliven Therapeutics, Inc. - USD -Infinity%
Kiora Pharmaceuticals, Inc. - USD -Infinity%
Iovance Biotherapeutics, Inc. 1.18 Million USD 97.477%
Taysha Gene Therapies, Inc. 15.45 Million USD 99.806%
Athira Pharma, Inc. - USD -Infinity%
Vaccinex, Inc. 570 Thousand USD 94.737%
HCW Biologics Inc. 2.84 Million USD 98.944%
XOMA Corporation 4.75 Million USD 99.369%
Nektar Therapeutics 90.12 Million USD 99.967%
Arvinas, Inc. 78.5 Million USD 99.962%
Tevogen Bio Holdings Inc. - USD -Infinity%
Merus N.V. 43.94 Million USD 99.932%
Omega Therapeutics, Inc. 3.09 Million USD 99.03%
Quince Therapeutics, Inc. - USD -Infinity%
Rezolute, Inc. - USD -Infinity%
Clene Inc. 654 Thousand USD 95.413%
Indaptus Therapeutics, Inc. - USD -Infinity%
BeyondSpring Inc. 1.75 Million USD 98.287%
Synlogic, Inc. 3.37 Million USD 99.11%
Allarity Therapeutics, Inc. - USD -Infinity%
Phio Pharmaceuticals Corp. - USD -Infinity%
Peak Bio, Inc. 367.87 Thousand USD 91.845%
Werewolf Therapeutics, Inc. 19.94 Million USD 99.85%
Krystal Biotech, Inc. 50.69 Million USD 99.941%
Karyopharm Therapeutics Inc. 146.03 Million USD 99.979%
SpringWorks Therapeutics, Inc. 5.44 Million USD 99.449%
Lipella Pharmaceuticals Inc. 449.61 Thousand USD 93.328%
MannKind Corporation 198.96 Million USD 99.985%
Ikena Oncology, Inc. 9.16 Million USD 99.672%
Cyclerion Therapeutics, Inc. - USD -Infinity%
Gyre Therapeutics, Inc. 113.45 Million USD 99.974%
Gossamer Bio, Inc. - USD -Infinity%
CohBar, Inc. - USD -Infinity%
Cognition Therapeutics, Inc. - USD -Infinity%
NRx Pharmaceuticals, Inc. - USD -Infinity%
Legend Biotech Corporation 285.14 Million USD 99.989%
Mural Oncology plc - USD -Infinity%
Biora Therapeutics, Inc. 4000.00 USD -650.0%
PaxMedica, Inc. Common Stock - USD -Infinity%
Disc Medicine, Inc. - USD -Infinity%
Champions Oncology, Inc. 50.15 Million USD 99.94%
REGENXBIO Inc. 90.24 Million USD 99.967%
Ensysce Biosciences, Inc. 2.23 Million USD 98.655%
Anavex Life Sciences Corp. - USD -Infinity%
Cellectar Biosciences, Inc. - USD -Infinity%
Edgewise Therapeutics, Inc. - USD -Infinity%
Vaxart, Inc. 7.37 Million USD 99.593%
PharmaCyte Biotech, Inc. - USD -Infinity%
Aldeyra Therapeutics, Inc. - USD -Infinity%
Cellectis S.A. 755 Thousand USD 96.026%
Longeveron Inc. 709 Thousand USD 95.769%
Repare Therapeutics Inc. 51.13 Million USD 99.941%
Sarepta Therapeutics, Inc. 1.24 Billion USD 99.998%
Inozyme Pharma, Inc. - USD -Infinity%
Revolution Medicines, Inc. 11.58 Million USD 99.741%
Nymox Pharmaceutical Corporation - USD -Infinity%
Third Harmonic Bio, Inc. - USD -Infinity%
ArriVent BioPharma, Inc. Common Stock - USD -Infinity%
AN2 Therapeutics, Inc. - USD -Infinity%
Anixa Biosciences, Inc. 210 Thousand USD 85.714%
Vertex Pharmaceuticals Incorporated 9.86 Billion USD 100.0%
Denali Therapeutics Inc. 330.53 Million USD 99.991%
Revelation Biosciences, Inc. - USD -Infinity%
Veru Inc. 16.29 Million USD 99.816%
Corvus Pharmaceuticals, Inc. - USD -Infinity%
Cingulate Inc. - USD -Infinity%
Passage Bio, Inc. - USD -Infinity%
Context Therapeutics Inc. - USD -Infinity%
Exicure, Inc. - USD -Infinity%
Day One Biopharmaceuticals, Inc. - USD -Infinity%
Oramed Pharmaceuticals Inc. 2.7 Million USD 98.89%
Revolution Medicines, Inc. Warrant 11.58 Million USD 99.741%
Scinai Immunotherapeutics Ltd. - USD -Infinity%
Rhythm Pharmaceuticals, Inc. 77.42 Million USD 99.961%
Nuvalent, Inc. - USD -Infinity%
ABVC BioPharma, Inc. 152.43 Thousand USD 80.319%
Carisma Therapeutics, Inc. 14.91 Million USD 99.799%
Unicycive Therapeutics, Inc. 675 Thousand USD 95.556%
OmniAb, Inc. 34.16 Million USD 99.912%
Anew Medical, Inc. - USD -Infinity%
Fennec Pharmaceuticals Inc. 21.25 Million USD 99.859%
Lipocine Inc. -2.85 Million USD 101.052%
Lexeo Therapeutics, Inc. Common Stock - USD -Infinity%
Nautilus Biotechnology, Inc. - USD -Infinity%
SAB Biotherapeutics, Inc. 2.23 Million USD 98.66%
G1 Therapeutics, Inc. 82.51 Million USD 99.964%
Bellerophon Therapeutics, Inc. - USD -Infinity%
Sage Therapeutics, Inc. 86.45 Million USD 99.965%
Ocugen, Inc. 6.03 Million USD 99.503%
Mind Medicine (MindMed) Inc. - USD -Infinity%
Q32 Bio Inc. 1.15 Million USD 97.405%
Brainstorm Cell Therapeutics Inc. - USD -Infinity%
Alumis Inc. Common Stock - USD -Infinity%
Equillium, Inc. 36.08 Million USD 99.917%
Kyverna Therapeutics, Inc. - USD -Infinity%
Coya Therapeutics, Inc. 6 Million USD 99.5%
CNS Pharmaceuticals, Inc. - USD -Infinity%
Galera Therapeutics, Inc. - USD -Infinity%
Evelo Biosciences, Inc. - USD -Infinity%
Comera Life Sciences Holdings, Inc. 633.1 Thousand USD 95.261%
Dominari Holdings Inc. 2.03 Million USD 98.529%
Edesa Biotech, Inc. - USD -Infinity%
vTv Therapeutics Inc. - USD -Infinity%
Bio-Techne Corporation 1.15 Billion USD 99.997%
Agios Pharmaceuticals, Inc. 26.82 Million USD 99.888%
Harmony Biosciences Holdings, Inc. 582.02 Million USD 99.995%
Prelude Therapeutics Incorporated - USD -Infinity%
Candel Therapeutics, Inc. - USD -Infinity%
iTeos Therapeutics, Inc. 12.59 Million USD 99.762%
Nkarta, Inc. - USD -Infinity%
BioCardia, Inc. 477 Thousand USD 93.711%
Iterum Therapeutics plc - USD -Infinity%